Qbic
7
7M
6
0.44
0.14
- Areas of investment
Summary
In 2007 was created Qbic, which is appeared as Corporate Investor. The company was established in Europe in United Kingdom. The main office of represented Corporate Investor is situated in the London.
The fund has no exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Belgium. Among the most successful fund investment fields, there are Service Industry, Biotechnology. Among the various public portfolio startups of the fund, we may underline AgroSavfe, PharmaFluidics
The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2013. The fund is constantly included in less than 2 deals per year.
The typical case for the fund is to invest in rounds with 7 participants. Despite the Qbic, startups are often financed by PMV, Qbic Fund, VIB. The meaningful sponsors for the fund in investment in the same round are PMV, VIB, Gimv. In the next rounds fund is usually obtained by VIB, Sofinnova Partners, PMV.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 0
- Rounds per year
- 0.44
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Agriculture (2)
- AgTech (2)
- Telecommunications (1) Show 10 more
- Investments by region
-
- Belgium (7)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Axithra | 05 Sep 2023 | Biotechnology, Health Care, Health Diagnostics | Seed | 11M | Limburg, Genk, Belgium |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.